Growth Metrics

Armata Pharmaceuticals, Inc. (ARMP) Net Cash Flow (2016 - 2018)

Armata Pharmaceuticals' Net Cash Flow history spans 6 years, with the latest figure at $2.4 million for Q4 2018.

  • For Q4 2018, Net Cash Flow rose 190.98% year-over-year to $2.4 million; the TTM value through Dec 2018 reached $1.3 million, up 320.73%, while the annual FY2024 figure was -$4.5 million, 185.02% down from the prior year.
  • Net Cash Flow for Q4 2018 was $2.4 million at Armata Pharmaceuticals, up from -$2.1 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $10.0 million in Q1 2015 and bottomed at -$11.4 million in Q2 2016.
  • The 5-year median for Net Cash Flow is -$2.6 million (2017), against an average of -$1.1 million.
  • The largest annual shift saw Net Cash Flow plummeted 2641.26% in 2014 before it surged 356.22% in 2015.
  • A 5-year view of Net Cash Flow shows it stood at -$3.2 million in 2014, then skyrocketed by 413.39% to $10.0 million in 2015, then plummeted by 82.64% to $1.7 million in 2016, then crashed by 248.68% to -$2.6 million in 2017, then skyrocketed by 190.98% to $2.4 million in 2018.
  • Per Business Quant, the three most recent readings for ARMP's Net Cash Flow are $2.4 million (Q4 2018), -$2.1 million (Q3 2018), and -$2.1 million (Q2 2018).